Two studies reveal promising treatments for breast cancer, enhancing options for patients with triple-negative breast cancer ...

A phase II clinical trial led by the Alliance for Clinical Trials in Oncology has met its primary endpoint, demonstrating ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today positive final results from the overall survival (OS) analysis of the Phase III INAVO120 study. These data showed ...

Fig 1. Patient selection. CVD, cardiovascular disease; Flemish Study on Environment, Genes and Health Outcomes; ICI, immune checkpoint inhibitor. The Ethics Committee of the University Hospitals ...